Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 1/2018

Open Access 01-12-2018 | Review

Making sense of early high-dose intravenous vitamin C in ischemia/reperfusion injury

Authors: Angelique M. E. Spoelstra-de Man, Paul W. G. Elbers, Heleen M. Oudemans-van Straaten

Published in: Critical Care | Issue 1/2018

Login to get access

Abstract

This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2018. Other selected articles can be found online at https://​www.​biomedcentral.​com/​collections/​annualupdate2018​. Further information about the Annual Update in Intensive Care and Emergency Medicine is available from http://​www.​springer.​com/​series/​8901.
Literature
1.
Grasner JT, Bottiger BW, Bossaert L. EuReCa ONE – ONE month – ONE Europe – ONE goal. Resuscitation. 2014;85:1307–8.CrossRefPubMed
2.
Beesems JA, Stieglis R, Koster RW. Reanimatie buiten het ziekenhuis in Noord-Holland en twente: resultaten ARREST-onderzoek. In: Koopman C, van Dis I, Visseren FLJ, Vaartjes I, Bots ML, editors. Hart- en vaatziekten in Nederland 2012, cijfers over risicofactoren, ziekte en sterfte. Den Haag: Hartstichting; 2012. p. 2006–11.
3.
4.
Zabet MH, Mohammadi M, Ramezani M, Khalili H. Effect of high-dose ascorbic acid on vasopressor’s requirement in septic shock. J Res Pharm Pract. 2016;5:94–100.CrossRefPubMedPubMedCentral
5.
Marik PE, Khangoora V, Rivera R, Hooper MH, Catravas J. Hydrocortisone, vitamin C and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study. Chest. 2016;151:1229–38.CrossRefPubMed
6.
Huet O, Dupic L, Batteux F, et al. Postresuscitation syndrome: potential role of hydroxyl radical-induced endothelial cell damage. Crit Care Med. 2011;39:1712–20.CrossRefPubMed
7.
Rice ME, Lee EJ, Choy Y. High levels of ascorbic acid, not glutathione, in the CNS of anoxia-tolerant reptiles contrasted with levels in anoxia-intolerant species. J Neurochem. 1995;64:1790–9.CrossRefPubMed
8.
Grooth HJ, Spoelstra-de Man AME, Oudemans-van Straaten HM. Early plasma Vitamin C concentration, organ dysfunction and ICU mortality. Intensive Care Med. 2014;40(Suppl 1):S199 (abst).
9.
Borrelli E, Roux-Lombard P, Grau GE, et al. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med. 1996;24:392–7.CrossRefPubMed
10.
van Zanten AR, Sztark F, Kaisers UX, et al. High-protein enteral nutrition enriched with immune-modulating nutrients vs standard high-protein enteral nutrition and nosocomial infections in the ICU: a randomized clinical trial. JAMA. 2014;312:514–24.CrossRefPubMed
11.
12.
Levine M, Padayatty SJ, Espey MG. Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries. Adv Nutr. 2011;2:78–88.CrossRefPubMedPubMedCentral
13.
Long CL, Maull KI, Krishnan RS, et al. Ascorbic acid dynamics in the seriously ill and injured. J Surg Res. 2003;109:144–8.CrossRefPubMed
14.
Tanaka H, Matsuda T, Miyagantani Y, et al. Reduction of resuscitation fluid volumes in severely burned patients using ascorbic acid administration: a randomized, prospective study. Arch Surg. 2000;135:326–31.CrossRefPubMed
15.
Hoffer LJ, Levine M, Assouline S, et al. Phase I clinical trial of i. v. ascorbic acid in advanced malignancy. Ann Oncol. 2008;19:1969–74.CrossRefPubMed
16.
Tsai MS, Huang CH, Tsai CY, et al. Ascorbic acid mitigates the myocardial injury after cardiac arrest and electrical shock. Intensive Care Med. 2011;37:2033–40.CrossRefPubMed
17.
Tsai MS, Huang CH, Tsai CY, et al. Combination of intravenous ascorbic acid administration and hypothermia after resuscitation improves myocardial function and survival in a ventricular fibrillation cardiac arrest model in the rat. Acad Emerg Med. 2014;21:257–65.CrossRefPubMed
18.
Motl J, Radhakrishnan J, Ayoub IM, Grmec S, Gazmuri RJ. Vitamin C compromises cardiac resuscitability in a rat model of ventricular fibrillation. Am J Ther. 2014;21:352–7.CrossRefPubMed
19.
Okazaki T, Otani H, Shimazu T, et al. Ascorbic acid and N-acetyl cysteine prevent uncoupling of nitric oxide synthase and increase tolerance to ischemia/reperfusion injury in diabetic rat heart. Free Radic Res. 2011;45:1173–83.CrossRefPubMed
20.
Klein HH, Pich S, Lindert S, et al. Combined treatment with vitamins E and C in experimental myocardial infarction in pigs. Am Heart J. 1989;118:667–73.CrossRefPubMed
21.
Doppelfeld IS, Parnham MJ. Experimental conditions determine effects of ascorbic acid on reperfusion injury: comparison of tissue damage with hemodynamic parameters in rat isolated hearts. Methods Find Exp Clin Pharmacol. 1992;14:419–30.PubMed
22.
Mickle DA, Li RK, Weisel RD, et al. Myocardial salvage with trolox and ascorbic acid for an acute evolving infarction. Ann Thorac Surg. 1989;47:553–7.CrossRefPubMed
23.
Chatziathanasiou GN, Nikas DN, Katsouras CS, et al. Combined intravenous treatment with ascorbic acid and desferrioxamine to reduce myocardial reperfusion injury in an experimental model resembling the clinical setting of primary PCI. Hell J Cardiol. 2012;53:195–204.
24.
Skyschally A, Schulz R, Gres P, Korth HG, Heusch G. Attenuation of ischemic preconditioning in pigs by scavenging of free oxyradicals with ascorbic acid. Am J Physiol Heart Circ Physiol. 2003;284:H698–703.CrossRefPubMed
25.
Nikas DN, Chatziathanasiou G, Kotsia A, et al. Effect of intravenous administration of antioxidants alone and in combination on myocardial reperfusion injury in an experimental pig model. Curr Ther Res Clin Exp. 2008;69:423–39.CrossRefPubMedPubMedCentral
26.
Guaiquil VH, Golde DW, Beckles DL, Mascareno EJ, Siddiqui MA. Vitamin C inhibits hypoxia-induced damage and apoptotic signaling pathways in cardiomyocytes and ischemic hearts. Free Radic Biol Med. 2004;37:1419–29.CrossRefPubMed
27.
Gao F, Yao CL, Gao E, et al. Enhancement of glutathione cardioprotection by ascorbic acid in myocardial reperfusion injury. J Pharmacol Exp Ther. 2002;301:543–50.CrossRefPubMed
28.
Tan DX, Manchester LC, Reiter RJ, et al. Ischemia/reperfusion-induced arrhythmias in the isolated rat heart: prevention by melatonin. J Pineal Res. 1998;25:184–91.CrossRefPubMed
29.
Karahaliou A, Katsouras C, Koulouras V, et al. Ventricular arrhythmias and antioxidative medication: experimental study. Hell J Cardiol. 2008;49:320–8.
30.
Woodward B, Zakaria MN. Effect of some free radical scavengers on reperfusion induced arrhythmias in the isolated rat heart. J Mol Cell Cardiol. 1985;17:485–93.CrossRefPubMed
31.
Nishinaka Y, Sugiyama S, Yokota M, Saito H, Ozawa T. The effects of a high dose of ascorbate on ischemia-reperfusion-induced mitochondrial dysfunction in canine hearts. Heart Vessel. 1992;7:18–23.CrossRef
32.
Molyneux CA, Glyn MC, Ward BJ. Oxidative stress and cardiac microvascular structure in ischemia and reperfusion: the protective effect of antioxidant vitamins. Microvasc Res. 2002;64:265–77.CrossRefPubMed
33.
34.
Basili S, Tanzilli G, Mangieri E, et al. Intravenous ascorbic acid infusion improves myocardial perfusion grade during elective percutaneous coronary intervention: relationship with oxidative stress markers. Jacc Cardiovasc Interv. 2010;3:221–9.CrossRefPubMed
35.
Wang ZJ, Hu WK, Liu YY, et al. The effect of intravenous vitamin C infusion on periprocedural myocardial injury for patients undergoing elective percutaneous coronary intervention. Can J Cardiol. 2014;30:96–101.CrossRefPubMed
36.
Guan W, Osanai T, Kamada T, et al. Time course of free radical production after primary coronary angioplasty for acute myocardial infarction and the effect of vitamin C. Jpn Circ J. 1999;63:924–8.CrossRefPubMed
37.
Lassnigg A, Punz A, Barker R, et al. Influence of intravenous vitamin E supplementation in cardiac surgery on oxidative stress: a double-blinded, randomized, controlled study. Br J Anaesth. 2003;90:148–54.CrossRefPubMed
38.
Dingchao H, Zhiduan Q, Liye H, Xiaodong F. The protective effects of high-dose ascorbic acid on myocardium against reperfusion injury during and after cardiopulmonary bypass. Thorac Cardiovasc Surg. 1994;42:276–8.CrossRefPubMed
39.
Sisto T, Paajanen H, Metsa-Ketela T, et al. Pretreatment with antioxidants and allopurinol diminishes cardiac onset events in coronary artery bypass grafting. Ann Thorac Surg. 1995;59:1519–23.CrossRefPubMed
40.
Hu X, Yuan L, Wang H, et al. Efficacy and safety of vitamin C for atrial fibrillation after cardiac surgery: a meta-analysis with trial sequential analysis of randomized controlled trials. Int J Surg. 2017;37:58–64.CrossRefPubMed
41.
Flamm ES, Demopoulos HB, Seligman ML, Poser RG, Ransohoff J. Free radicals in cerebral ischemia. Stroke. 1978;9:445–7.CrossRefPubMed
42.
Huang J, Agus DB, Winfree CJ, et al. Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke. Proc Natl Acad Sci U S A. 2001;98:11720–4.CrossRefPubMedPubMedCentral
43.
Mack WJ, Mocco J, Ducruet AF, et al. A cerebroprotective dose of intravenous citrate/sorbitol-stabilized dehydroascorbic acid is correlated with increased cerebral ascorbic acid and inhibited lipid peroxidation after murine reperfused stroke. Neurosurgery. 2006;59:383–8.CrossRefPubMed
44.
Song J, Park J, Kim JH, et al. Dehydroascorbic acid attenuates ischemic brain edema and neurotoxicity in cerebral ischemia: an in vivo study. Exp Neurobiol. 2015;24:41–54.CrossRefPubMedPubMedCentral
45.
Bemeur C, Ste-Marie L, Desjardins P, et al. Expression of superoxide dismutase in hyperglycemic focal cerebral ischemia in the rat. Neurochem Int. 2004;45:1167–74.CrossRefPubMed
46.
Henry PT, Chandy MJ. Effect of ascorbic acid on infarct size in experimental focal cerebral ischaemia and reperfusion in a primate model. Acta Neurochir. 1998;140:977–80.CrossRefPubMed
47.
Ranjan A, Theodore D, Haran RP, Chandy MJ. Ascorbic acid and focal cerebral ischaemia in a primate model. Acta Neurochir. 1993;123:87–91.CrossRefPubMed
48.
Stamford JA, Isaac D, Hicks CA, et al. Ascorbic acid is neuroprotective against global ischaemia in striatum but not hippocampus: histological and voltammetric data. Brain Res. 1999;835:229–40.CrossRefPubMed
49.
Kim EJ, Park YG, Baik EJ, et al. Dehydroascorbic acid prevents oxidative cell death through a glutathione pathway in primary astrocytes. J Neurosci Res. 2005;79:670–9.CrossRefPubMed
50.
Lagowska-Lenard M, Stelmasiak Z, Bartosik-Psujek H. Influence of vitamin C on markers of oxidative stress in the earliest period of ischemic stroke. Pharmacol Rep. 2010;62:751–6.CrossRefPubMed
Metadata
Title
Making sense of early high-dose intravenous vitamin C in ischemia/reperfusion injury
Authors
Angelique M. E. Spoelstra-de Man
Paul W. G. Elbers
Heleen M. Oudemans-van Straaten
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2018
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-018-1996-y

Other articles of this Issue 1/2018

Critical Care 1/2018 Go to the issue

Research

The interleukin-27 -964A>G polymorphism enhances sepsis-induced inflammatory responses and confers susceptibility to the development of sepsis

Editorial

Artificial oxygen carriers: a new future?

Research

Identification of a transcriptome profile associated with improvement of organ function in septic shock patients after early supportive therapy

Commentary

Do we need new trials of procalcitonin-guided antibiotic therapy?

Letter

Feasibility, safety, and utility of bronchoscopy in patients with ARDS while in the prone position

Research

Refractory out-of-hospital cardiac arrest with ongoing cardiopulmonary resuscitation at hospital arrival – survival and neurological outcome without extracorporeal cardiopulmonary resuscitation